OLR1 drives gastric cancer progression through NF-κB activation and immunosuppressive macrophage polarization
Medical Oncology · 2026
DOI: 10.1007/s12032-026-03394-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Oncology, 2026. Verfasst von Zhimin Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, Changzhou Maternal and Child Health Care Hospital, Changzhou Medical Center, Nanjing Medical University, Chan…. Hauptthemen laut MEDLINE: Stomach Neoplasms, NF-kappa B, Scavenger Receptors, Class E, Macrophages. Die Arbeit nennt 42 Literaturangaben. Gefördert von: Application Foundation Project of Changzhou Science and Technology Bureau, the General Project of Nanjing Medical University.
Abstract (Originalsprache)
Gastric cancer remains a leading cause of cancer-related mortality worldwide, and the identification of clinically relevant biomarkers is critical for improving patient outcomes. Oxidized low-density lipoprotein receptor 1 (OLR1) has been implicated in tumor progression; however, its role in gastric cancer and the tumor microenvironment remains unclear. OLR1 expression and clinical significance were analyzed using The Cancer Genome Atlas (TCGA) dataset and validated in gastric cancer cell lines. Gain- and loss-of-function experiments, together with in vitro and in vivo assays, were performed to investigate the biological functions and underlying mechanisms of OLR1 in gastric cancer progression. OLR1 was significantly upregulated in gastric cancer and associated with unfavorable prognosis. Functional analyses demonstrated that OLR1 promoted gastric cancer cell proliferation, migration, and tumor growth. Mechanistically, OLR1 activated NF-κB signaling and facilitated macrophage polarization toward the M2 phenotype, thereby contributing to a protumorigenic microenvironment. OLR1 promotes gastric cancer progression through activation of NF-κB signaling and modulation of macrophage polarization. These findings identify OLR1 as a potential prognostic biomarker and therapeutic target for gastric cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastrointestinal Surgery, Changzhou Maternal and Child Health Care Hospital, Changzhou Medical Center, Nanjing Medical University, Changzhou, Jiangsu, China.
- Department of General Practice, Diaozhuang Street Community Health Center, Changzhou, Jiangsu, China.
- Department of Hepatological Surgery, Changzhou Maternal and Child Health Care Hospital, Changzhou Medical Center, Nanjing Medical University, Changzhou, Jiangsu, China. 13616118836@163.com.
ORCID-Profile: Xiao Zhou
Förderung
- Application Foundation Project of Changzhou Science and Technology Bureau
- the General Project of Nanjing Medical University
Zitieren
APA
Chen, Z., Wang, Y., Xu, X., Zhao, M., & Zhou, X. (2026). OLR1 drives gastric cancer progression through NF-κB activation and immunosuppressive macrophage polarization. Medical Oncology. https://doi.org/10.1007/s12032-026-03394-4
Vancouver
Chen Z, Wang Y, Xu X, Zhao M, Zhou X. OLR1 drives gastric cancer progression through NF-κB activation and immunosuppressive macrophage polarization. Medical Oncology. 2026. doi:10.1007/s12032-026-03394-4
BibTeX
@article{Chen2026,
author = {Chen, Zhimin and Wang, Yuke and Xu, Xiaojia and Zhao, Min and Zhou, Xiao},
title = {OLR1 drives gastric cancer progression through NF-κB activation and immunosuppressive macrophage polarization},
journal = {Medical Oncology},
year = {2026},
doi = {10.1007/s12032-026-03394-4}
}
EUVIMED